Nucleotide analogs

US9932623B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9932623-B2
Application numberUS-201414463412-A
CountryUS
Kind codeB2
Filing dateAug 19, 2014
Priority dateAug 19, 2013
Publication dateApr 3, 2018
Grant dateApr 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein is technology relating to the manipulation and detection of nucleic acids, including but not limited to compositions, systems, methods, and kits related to nucleotides comprising 3′-O-propargyl deoxynucleotides wherein the 3′-O-propargyl deoxynucleotides are linked to a nucleic acid by a polymerase.

First claim

Opening claim text (preview).

We claim: 1. A reaction mixture comprising one or more dNTPs, one or more 3′-O-propargyl nucleotide analogs, and a polymerase. 2. The reaction mixture of claim 1 further comprising a target nucleic acid. 3. The reaction mixture of claim 1 wherein the ratio of dNTPs to 3′-O-propargyl nucleotide analogs is from 1:500 to 500:1. 4. The reaction mixture of claim 1 wherein said polymerase is a polymerase from a Thermococcus species 9° N-7 and comprising one or more mutations selected from D141A, E143A, Y409V, and A485L. 5. The reaction mixture of claim 1 comprising a primer comprising an index or a barcode. 6. The reaction mixture of claim 1 comprising a target nucleic acid that is an amplicon. 7. A next generation sequencing (NGS) library comprising a plurality of nucleic acids, wherein each nucleic acid comprises a 3′-O-propargyl-nucleotide. 8. The NGS library of claim 7 wherein each nucleic acid of the plurality of nucleic acids comprises a subsequence of a target nucleic acid sequence. 9. The NGS library of claim 7 wherein each nucleic acid of the plurality of nucleic acids is conjugated to an oligonucleotide by a triazole linkage. 10. The NGS library of claim 7 comprising a plurality of 3′-O-propargyl-dN terminated nucleic acids. 11. The NGS library of claim 7 wherein each nucleic acid of the plurality of nucleic acids comprises an index or a barcode. 12. The NGS library of claim 7 wherein each nucleic acid of the plurality of nucleic acids comprises an adaptor oligonucleotide. 13. A NGS library produced by a method comprising synthesizing a plurality of nucleic acids using a mixture of dNTPs and one or more 3′-O-propargyl nucleotide analogs. 14. The NGS library of claim 13 wherein the molar ratio of dNTPs to 3′-O-propargyl nucleotide analogs is from 1:500 to 500:1. 15. The NGS library of claim 13 wherein the synthesis is performed by a Thermococcus species 9° N-7 and comprising one or more mutations selected from D141A, E143A, Y409V, and A485L. 16. The NGS library of claim 13 comprising a plurality of nucleic acids, wherein each nucleic acid of the plurality of nucleic acids comprises a subsequence of a target nucleic acid sequence. 17. The NGS library of claim 13 comprising a plurality of nucleic acids, wherein each nucleic acid of the plurality of nucleic acids is conjugated to an oligonucleotide by a triazole linkage. 18. The NGS library of claim 13 comprising a plurality of 3′-O-propargyl-dN terminated nucleic acids. 19. The NGS library of claim 13 comprising a plurality of nucleic acids, wherein each nucleic acid of the plurality of nucleic acids comprises an index or a barcode. 20. The NGS library of claim 13 comprising a plurality of nucleic acids, wherein each nucleic acid of the plurality of nucleic acids comprises an adaptor oligonucleotide.

Assignees

Inventors

Classifications

  • General methods of preparing gene libraries, not provided for in other subgroups · CPC title

  • Methods for sequencing · CPC title

  • C07H19/10Primary

    with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • C07H19/20Primary

    with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9932623B2 cover?
Provided herein is technology relating to the manipulation and detection of nucleic acids, including but not limited to compositions, systems, methods, and kits related to nucleotides comprising 3′-O-propargyl deoxynucleotides wherein the 3′-O-propargyl deoxynucleotides are linked to a nucleic acid by a polymerase.
Who is the assignee on this patent?
Abbott Molecular Inc
What technology area does this patent fall under?
Primary CPC classification C07H19/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).